These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 24411285)
1. Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome. Stefanescu A; Macklin EA; Lin E; Dudzinski DM; Johnson J; Kennedy KF; Jacoby D; DeFaria Yeh D; Lewis GD; Yeh RW; Liberthson R; Lui G; Bhatt AB Am J Cardiol; 2014 Mar; 113(5):865-70. PubMed ID: 24411285 [TBL] [Abstract][Full Text] [Related]
2. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Diller GP; Dimopoulos K; Okonko D; Li W; Babu-Narayan SV; Broberg CS; Johansson B; Bouzas B; Mullen MJ; Poole-Wilson PA; Francis DP; Gatzoulis MA Circulation; 2005 Aug; 112(6):828-35. PubMed ID: 16061735 [TBL] [Abstract][Full Text] [Related]
3. Validation of mortality risk stratification models for cardiovascular disease. Nakayama M; Osaki S; Shimokawa H Am J Cardiol; 2011 Aug; 108(3):391-6. PubMed ID: 21600539 [TBL] [Abstract][Full Text] [Related]
4. Four-variable risk model in men and women with heart failure. Chyu J; Fonarow GC; Tseng CH; Horwich TB Circ Heart Fail; 2014 Jan; 7(1):88-95. PubMed ID: 24281135 [TBL] [Abstract][Full Text] [Related]
5. Anemia in adults with congenital heart disease relates to adverse outcome. Dimopoulos K; Diller GP; Giannakoulas G; Petraco R; Chamaidi A; Karaoli E; Mullen M; Swan L; Piepoli MF; Poole-Wilson PA; Francis DP; Gatzoulis MA J Am Coll Cardiol; 2009 Nov; 54(22):2093-100. PubMed ID: 19926019 [TBL] [Abstract][Full Text] [Related]
6. Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model. Pamboukian SV; Tallaj JA; Brown RN; Nielsen T; George JF; Kirklin JK; Holman WL; Levy WC ASAIO J; 2012; 58(2):93-7. PubMed ID: 22370679 [TBL] [Abstract][Full Text] [Related]
9. Specialized adult congenital heart disease care: the impact of policy on mortality. Mylotte D; Pilote L; Ionescu-Ittu R; Abrahamowicz M; Khairy P; Therrien J; Mackie AS; Marelli A Circulation; 2014 May; 129(18):1804-12. PubMed ID: 24589851 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States. Rodriguez FH; Moodie DS; Parekh DR; Franklin WJ; Morales DL; Zafar F; Adams GJ; Friedman RA; Rossano JW Congenit Heart Dis; 2013; 8(6):513-9. PubMed ID: 23164196 [TBL] [Abstract][Full Text] [Related]
11. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Tutarel O; Kempny A; Alonso-Gonzalez R; Jabbour R; Li W; Uebing A; Dimopoulos K; Swan L; Gatzoulis MA; Diller GP Eur Heart J; 2014 Mar; 35(11):725-32. PubMed ID: 23882067 [TBL] [Abstract][Full Text] [Related]
12. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Gorodeski EZ; Chu EC; Chow CH; Levy WC; Hsich E; Starling RC Circ Heart Fail; 2010 Nov; 3(6):706-14. PubMed ID: 20798278 [TBL] [Abstract][Full Text] [Related]
13. Midterm results of surgery for adults with congenital heart disease centralized to a Swedish cardiothoracic center. Nozohoor S; Gustafsson R; Kallonen J; Sjögren J Congenit Heart Dis; 2013; 8(4):273-80. PubMed ID: 22967060 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk indices in continuous-flow left ventricular assist device patients. Schaffer JM; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV Ann Thorac Surg; 2009 Dec; 88(6):1889-96. PubMed ID: 19932256 [TBL] [Abstract][Full Text] [Related]
15. Impact of adult congenital heart disease on survival and mortality after heart transplantation. Burchill LJ; Edwards LB; Dipchand AI; Stehlik J; Ross HJ J Heart Lung Transplant; 2014 Nov; 33(11):1157-63. PubMed ID: 25049065 [TBL] [Abstract][Full Text] [Related]
16. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Zomer AC; Vaartjes I; van der Velde ET; de Jong HM; Konings TC; Wagenaar LJ; Heesen WF; Eerens F; Baur LH; Grobbee DE; Mulder BJ Int J Cardiol; 2013 Oct; 168(3):2487-93. PubMed ID: 23602867 [TBL] [Abstract][Full Text] [Related]
17. Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease. Ohuchi H; Yasuda K; Ono S; Hayama Y; Negishi J; Noritake K; Mizuno M; Iwasa T; Miyazaki A; Yamada O Int J Cardiol; 2014 Jun; 174(2):306-12. PubMed ID: 24780541 [TBL] [Abstract][Full Text] [Related]
18. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Mozaffarian D; Anker SD; Anand I; Linker DT; Sullivan MD; Cleland JG; Carson PE; Maggioni AP; Mann DL; Pitt B; Poole-Wilson PA; Levy WC Circulation; 2007 Jul; 116(4):392-8. PubMed ID: 17620506 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population. Levy WC; Aaronson KD; Dardas TF; Williams P; Haythe J; Mancini D J Heart Lung Transplant; 2012 Aug; 31(8):817-24. PubMed ID: 22759798 [TBL] [Abstract][Full Text] [Related]
20. Rate of inducible ventricular arrhythmia in adults with congenital heart disease. Tsai SF; Chan DP; Ro PS; Boettner B; Daniels CJ Am J Cardiol; 2010 Sep; 106(5):730-6. PubMed ID: 20723654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]